Panos Karagiannis

6PUBLICATIONS
23CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 09, 2026
Degron-independent recruitment of KAT2A expands the target space of CRBN molecular glues.

|Jul 05, 2022
Retrospective analysis of three induction chemotherapy regimens in acute myeloid leukemia including CPX-351, cytarabine/daunorubicin with and without the addition of cladribine.

Felix Klingler, Winfried H Alsdorf, Susanne Ghandili

|Mar 10, 2022
Immunotherapy in Advanced Prostate Cancer-Light at the End of the Tunnel?

Gunhild von Amsberg, Winfried Alsdorf, Panagiotis Karagiannis

|Sep 13, 2021
In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart.

Francis Man, Alexander Koers, Panagiotis Karagiannis

|Jul 01, 2020
Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis.

Panagiotis Karagiannis, Lena Sänger, Winfried Alsdorf

Pageof 1

Frequent Collaborators

1 joint publications

Francis Man

1 joint publications

Debra H Josephs

1 joint publications

Heather J Bax

1 joint publications

Silvia Mele